Eli Lilly's obesity drug Mounjaro will be available through Britain's state health system for some patients from March, after ...

Former FDA Commissioner Dr. Scott Gottlieb joins 'Squawk Box' to discuss the future of pharmaceutical advertising, health ...

Jim Gaffigan opened up about shedding 50 pounds on The View, sharing a moment with co-host Whoopi Goldberg as they discussed ...

Consumers who take copies of the weight loss drug Zepbound and diabetes drug Mounjaro will need to find a new source for ...

Tirzepatide, the active ingredient in both Mounjaro for type 2 diabetes and Zepbound for weight loss, was in short supply for ...

The Food and Drug Administration (FDA) has reaffirmed that Mounjaro and Zepbound are no longer in shortage following a ...

Britons paying privately for obesity drugs are increasingly choosing Eli Lilly's Mounjaro over Novo Nordisk's Wegovy, online ...

The FDA has declared the end of the two-year shortages of Eli Lilly's Mounjaro and Zepbound — used to treat diabetes and weight loss, respectively — and has reaffirmed its decision to halt the ...

Eli Lilly & Co.’s weight-loss and diabetes drug Mounjaro won’t be reclassified as a sleep apnea treatment in Europe, with ...

The active ingredients in Ozempic, Mounjaro, and similar medications mimic hormones that help regulate blood sugar and create ...

Mounjaro is a prescription glucagon-like peptide-1 (GLP-1) drug with the active ingredient tirzepatide. Doctors prescribe it for the treatment of type 2 diabetes, but they may also prescribe it ...

Mounjaro (tirzepatide) has potential interactions with other medications and some supplements. For example, Mounjaro can interact with Adderall and oral birth control. An interaction can occur ...